Balchem Corporation
NASDAQ:BCPCChemicals - Specialty
+$1.03 today
- Market cap
- $5.36B
- Beta
- 0.83
- P/E (TTM)
- 33.8
- EPS (TTM)
- $4.90
- Dividend yield
- 0.58%
Volume 0.21M
Average 0.21M
BCPC Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Balchem CorporationNASDAQ: BCPC
Capital Expenditures · Q3 FY2026 · quarter ended Sep 2026
Capital expenditures turns positive
Q3 FY2026 capital expenditures was $17.14M, compared with -$14.9M a year earlier. Trailing-twelve-month capital expenditures was -$16.21M. Over 3 fiscal years it compounded at -4.7% a year.
Context
- Capital expenditures amounted to 4.2% of revenue in FY2025, up 0.5 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
What to watch
Whether quarterly capital expenditures holds near $17.14M or moves back toward the trailing-twelve-month quarterly average of -$4.05M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (43.49M) USD
- Year-over-year change
- -22.0%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (43.49M) | -22.0% |
| FY2024 | 2024-12-31 | (35.66M) | +5.9% |
| FY2023 | 2023-12-31 | (37.89M) | +24.7% |
| FY2022 | 2022-12-31 | (50.29M) | -34.3% |
| FY2021 | 2021-12-31 | (37.45M) | — |
Capital Expenditures vs competitors
How BCPC compares with its peers on the latest reported figures
- BCPC's LTM Sep 2026 capital expenditures of $16.21M is the smallest of the 11 companies compared; the peer median is $135.44M.
- Its year-over-year change of -59.5% is the lowest of 11, against a peer median of +18.4%.
- Capital expenditures amounts to 1.5% of revenue for BCPC, versus a peer median of 5.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $625M | +15.3% | +5.5% | 6.3% | |
| LTM Jun 2026 | $452M | -23.8% | -3.7% | 5.1% | |
| LTM Aug 2026 | $189.33M | +56.4% | +3.1% | 5.3% | |
| LTM Mar 2026 | $177.13M | +356.6% | -25.9% | 7.6% | |
| LTM Jun 2026 | $152M | -59.4% | +13.0% | 2.1% | |
| LTM Jun 2026 | $118.89M | +59.8% | +4.1% | 7.0% | |
| LTM Sep 2026 | $108.8M | +3.3% | +0.3% | 3.2% | |
| LTM Jun 2026 | $71M | -30.4% | -4.6% | 3.9% | |
| LTM Jun 2026 | $60.6M | +21.4% | +5.9% | 3.3% | |
| LTM Sep 2026 | $56.25M | +27.4% | +6.4% | 4.9% | |
| LTM Sep 2026 | $16.21M | -59.5% | -4.7% | 1.5% | |
| Peer median (excluding BCPC) | $135.44M | +18.4% | +3.6% | 5.0% | |
Competitors are the stored peer set for BCPC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 96.1M | 105.37M | 108.54M | 128.48M | 154.85M |
| Depreciation & Amortization | 48.88M | 51.85M | 54.94M | 47.97M | 45.69M |
| Deferred Income Tax | (5.94M) | (8.36M) | (10.81M) | (6.78M) | 6.26M |
| Stock-Based Compensation | 10.8M | 13.22M | 16.05M | 16.68M | 18.06M |
| Change in Working Capital | 10.93M | (25.22M) | 20.01M | (6.12M) | (7.46M) |
| Accounts Receivables | (20.7M) | (3.62M) | 6.97M | 5.58M | (20.85M) |
| Inventory | (21.02M) | (7.8M) | 10.53M | (22.79M) | 3.64M |
| Accounts Payables | 46.19M | (15.54M) | 3.55M | 9.07M | 11.29M |
| Other Working Capital | 6.47M | 1.74M | (1.04M) | 2.03M | (1.54M) |
| Other Non-Cash Items | (257K) | 1.68M | (4.97M) | 1.77M | (835K) |
| Operating Cash Flow | 160.51M | 138.54M | 183.76M | 182M | 216.56M |
| Capital Expenditures | (37.45M) | (50.29M) | (37.89M) | (35.66M) | (43.49M) |
| Acquisitions (Net) | 318K | (365.78M) | (1.54M) | (24.16M) | (49K) |
| Purchases of Investments | 0 | 0 | 0 | 0 | (353K) |
| Sales of Investments | 0 | 0 | 2.74M | 0 | 0 |
| Other Investing Activities | 1.83M | 56K | 1.88M | 89K | 0 |
| Investing Cash Flow | (35.3M) | (416.01M) | (34.81M) | (59.74M) | (43.89M) |
| Debt Repayment | (55.16M) | 300.84M | (131.22M) | (119.79M) | (26.19M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 9.31M |
| Common Stock Repurchased | (35.24M) | (35.42M) | (4.47M) | (5.68M) | (107.64M) |
| Dividends Paid | (18.72M) | (20.71M) | (22.87M) | (25.58M) | (28.29M) |
| Other Financing Activities | 6.94M | 1.98M | 5.24M | 17.23M | 0 |
| Financing Cash Flow | (102.18M) | 246.68M | (153.32M) | (133.82M) | (152.81M) |
| Effect of Forex Changes | (4.37M) | (5.88M) | 2.26M | (3.38M) | 5.2M |
| Net Change in Cash | 18.67M | (36.68M) | (2.11M) | (14.93M) | 25.06M |
| Free Cash Flow | 123.07M | 88.25M | 145.87M | 146.34M | 173.07M |
Balchem Corporation
NASDAQ:BCPC
Intrinsic Alpha fair value
Locked
Current Price
$168.73
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.